<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Child Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Child Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Русский журнал детской неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-8803</issn><issn publication-format="electronic">2412-9178</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">496</article-id><article-id pub-id-type="doi">10.17650/2073-8803-2024-19-4-52-57</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Intellectual development disorder syndrome with congenital anomalies of type 99, faceted female (OMIM: 300968), updated mutation in the USP9X gene</article-title><trans-title-group xml:lang="ru"><trans-title>Синдром задержки интеллектуального развития с врожденными аномалиями 99-го типа, ограниченный женским полом (oMiM: 300968), обусловленный новой мутацией в гене USP9X</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-0064-0448</contrib-id><name-alternatives><name xml:lang="en"><surname>Latypov</surname><given-names>A. Sh.</given-names></name><name xml:lang="ru"><surname>Латыпов</surname><given-names>А. Ш.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>61/2 Shchepkina St., Moscow 129110</p></bio><bio xml:lang="ru"><p>129110 Москва, ул. Щепкина, 61/2</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-4865-433X</contrib-id><name-alternatives><name xml:lang="en"><surname>Proskurin</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Проскурина</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>61/2 Shchepkina St., Moscow 129110</p></bio><bio xml:lang="ru"><p>129110 Москва, ул. Щепкина, 61/2</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4113-5799</contrib-id><name-alternatives><name xml:lang="en"><surname>Sidorova</surname><given-names>O. P.</given-names></name><name xml:lang="ru"><surname>Сидорова</surname><given-names>О. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Olga Petrovna Sidorova </p><p>61/2 Shchepkina St., Moscow 129110</p></bio><bio xml:lang="ru"><p>Ольга Петровна Сидорова </p><p>129110 Москва, ул. Щепкина, 61/2</p></bio><email>sidorovaop2019@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6374-9786</contrib-id><name-alternatives><name xml:lang="en"><surname>Vasilenko</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Василенко</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>61/2 Shchepkina St., Moscow 129110</p></bio><bio xml:lang="ru"><p>129110 Москва, ул. Щепкина, 61/2</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6759-9121</contrib-id><name-alternatives><name xml:lang="en"><surname>Kassina</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Кассина</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>61/2 Shchepkina St., Moscow 129110</p></bio><bio xml:lang="ru"><p>129110 Москва, ул. Щепкина, 61/2</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6436-0249</contrib-id><name-alternatives><name xml:lang="en"><surname>Bunak</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Бунак</surname><given-names>М. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>61/2 Shchepkina St., Moscow 129110</p></bio><bio xml:lang="ru"><p>129110 Москва, ул. Щепкина, 61/2</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">M.F. Vladimirsky Moscow Regional Research Clinical Institute</institution></aff><aff><institution xml:lang="ru">ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2024</year></pub-date><volume>19</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>52</fpage><lpage>57</lpage><history><date date-type="received" iso-8601-date="2025-01-22"><day>22</day><month>01</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-01-22"><day>22</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, АБВ-пресс</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://rjdn.abvpress.ru/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://rjdn.abvpress.ru/jour/article/view/496">https://rjdn.abvpress.ru/jour/article/view/496</self-uri><abstract xml:lang="en"><p>The syndrome of mental retardation with congenital anomalies of type 99, limited to the female sex (OMIM: 300968) is an X-linked dominant disorder of the development of the central nervous system, characterized by delayed psychomotor development and mild or moderate mental retardation.</p><p>In the article, a clinical case of a 2-year-old 8-month-old patient with mental retardation syndrome and type 99 congenital anomalies characteristic only of the female sex (OMIM: 300968) is presented. Due to the heterozygous carriage of a previously undescribed pathogenic variant with a reading frame shift in the X-linked <italic>USP9X</italic> gene associated with a type 99 developmental disorder with dominant inheritance, in chrX:41196714AATTG&gt;A, ENST00000378308, C.4214_4217delATT.P.Asp1405fs. The pathogenic variant was confirmed in the child in the study of the trio by Sanger. It is absent from the parents (a new pathogenic variant). Along with cognitive impairments, the patient revealed congenital anomalies, some of which coincided with those previously described. There were also some special features: the asymmetry of the skull in the described patient was expressed in the parietal part of the skull, and not the facial one, as described in previous publications. Secondary mitochondrial disorders were revealed during the study of the activity of mitochondrial enzymes in peripheral blood lymphocytes, which are an “enzymatic mirror” of tissues, which is an indication for the appointment of energotropic drugs (succinic acid and carnitine).</p></abstract><trans-abstract xml:lang="ru"><p>Синдром задержки интеллектуального развития с врожденными аномалиями 99-го типа, ограниченный женским полом (OMIM: 300968), – это Х-сцепленное доминантное нарушение развития центральной нервной системы, характеризующееся задержкой психомоторного развития и легкой или умеренной умственной отсталостью.</p><p>В статье представлен клинический случай пациентки 2 лет 8 мес с синдромом задержки интеллектуального развития с врожденными аномалиями 99-го типа, ограниченным женским полом (OMIM: 300968), обусловленным гетерозиготным носительством ранее не описанного патогенного варианта со сдвигом рамки считывания в Х-сцепленном гене <italic>USP9X</italic><bold>, </bold>ассоциированном с синдромальной формой нарушения развития 99-го типа с доминантным наследованием, в chrX:41196714AATTG&gt;A, ENST00000378308, C.4214_4217delATT.P.Asp1405fs. При проведении исследования трио по сэнгеру патогенный вариант подтвержден у ребенка, отсутствует у родителей (новый патогенный вариант). Наряду с когнитивными нарушениями у пациентки выявлены врожденные аномалии, часть из которых совпала с ранее описанными, но имелись и свои особенности: асимметрия черепа у описанной больной выражена в теменной части черепа, а не лицевой, как это было описано в предыдущих публикациях. Выявлены вторичные митохондриальные нарушения при исследовании активности митохондриальных ферментов в лимфоцитах периферической крови, которые являются «энзематическим зеркалом» тканей, что служит показанием к назначению энерготропных препаратов (янтарной кислоты и карнитина).</p></trans-abstract><kwd-group xml:lang="en"><kwd>intellectual retardation</kwd><kwd>congenital anomalies</kwd><kwd>USP9X mutation (OMIM: 300968)</kwd><kwd>mitochondria</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>задержка интеллектуального развития</kwd><kwd>врожденные аномалии</kwd><kwd>мутация в гене USP9X (OMIM: 300968)</kwd><kwd>митохондрии</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Kurbatova O.V., Izmaylova T.D., Surkov A.N. et al. Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease. Vestnik Rossiyskoy akademii meditsinskikh nauk = Bulletin of the Russian Academy of Medical Sciences 2014;69(7–8):78–84. (In Russ.). DOI: 10.15690/vramn.v69i7-8.1112</mixed-citation><mixed-citation xml:lang="ru">Курбатова О.В., Измайлова Т.Д., Сурков А.Н. и др. Митохондриальная дисфункция у детей с печеночными формами гликогеновой болезни. Вестник Российской академии медицинских наук 2014;69(7–8):78–84. DOI: 10.15690/vramn.v69i7-8.1112</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Brett M., McPherson J., Zang Z.J. et al. Massively parallel sequencing of patients with intellectual disability, congenital anomalies and/or autism spectrum disorders with a targeted gene panel. PLoS One 2014;9(4):e93409. DOI: 10.1371/journal.pone.0093409</mixed-citation><mixed-citation xml:lang="ru">Brett M., McPherson J., Zang Z.J. et al. Massively parallel sequencing of patients with intellectual disability, congenital anomalies and/or autism spectrum disorders with a targeted gene panel. PLoS One 2014;9(4):e93409. DOI: 10.1371/journal.pone.0093409</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Reijnders M.R.F., Zachariadis V., Latour B. et al. De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations. Am J Hum Genet 2016;98(2):373–81. DOI: 10.1016/j.ajhg.2015.12.015</mixed-citation><mixed-citation xml:lang="ru">Reijnders M.R.F., Zachariadis V., Latour B. et al. De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations. Am J Hum Genet 2016;98(2):373–81. DOI: 10.1016/j.ajhg.2015.12.015</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Sisoudiya S.D., Mishra P., Li He et al. Identification of USP9X as a leukemia susceptibility gene. Blood Adv 2023;22;7(16):4563–75. DOI: 10.1182/bloodadvances.2023009814</mixed-citation><mixed-citation xml:lang="ru">Sisoudiya S.D., Mishra P., Li He et al. Identification of USP9X as a leukemia susceptibility gene. Blood Adv 2023;22;7(16):4563–75. DOI: 10.1182/bloodadvances.2023009814</mixed-citation></citation-alternatives></ref></ref-list></back></article>
